About The Position

Global Pricing and Market Access (GPMA) are key to maximizing the value of our products for patients, healthcare systems and for the company. In order to further strengthen our capability in this critical function, we are looking for a senior leader to join the GPMA team who will bring technical and organizational expertise in strategic pricing and global market access in Specialty Medicines, as well as lead his/her respective team as we build our skills and capabilities consistently across the product areas. The Senior Director Specialty Medicines GPMA will partner closely with key stakeholders in R&D, Commercial, Medical, RWE, Government Affairs, Policy, and other functions to secure the early input and evidence generation required to deliver competitive Target Medicine Profiles, clinical and real-world development plans, and the delivery of reimbursable dossiers for the markets. Strong collaboration with Regional and local access teams will also be essential to further strengthen our ability to reward innovation and make our products accessible to the patients who will benefit most.

Requirements

  • Advanced Degree in Business, Medicine, Pharmacy, Health Economics, Health Policy or Science
  • 15+ years of relevant experience acquired at pharmaceutical companies, Payer or Health Technology Assessment agencies, physician associations or relevant consultancy companies in a multi-national context
  • 5+ years of experience working in an above-country role/Global team in the market access space
  • 5+ years of experience working in the US payer or access environment
  • 3+ years of People Management experience

Nice To Haves

  • Demonstrated ability to think strategically, manage uncertainty, and make sound global market access and pricing recommendations throughout the lifecycle
  • Agility and flexibility to support evolving team and business needs; recognized team player/coach
  • Exceptional oral and written communication skills, including the ability to develop and deliver effective presentations to senior leadership and tailor for different audiences
  • Demonstrated ability to effectively lead cross-functional matrix teams and build relationships across functions and geographies
  • Appreciation for External Relations and Public Health Issues in Specialty Medicine

Responsibilities

  • Lead a team that will provide strategic advice and leadership to assigned Respiratory, Inflammation and Immunology Disease Area globally with respect to market access and pricing, to develop innovative and competitive Payer Value Propositions and Pricing Strategies for launch and pipeline assets.
  • Deliverables from the team at a cross-portfolio level will include: Development of GSK’s global strategy on pricing and access, embedded in the Integrated Asset Plan (IAP) Customer insight into pricing and access trends Innovation in approaches to pricing and access Foresight into direction of travel for payers and development of GSK’s position on Payer approaches
  • Deliverables to support individual assets within the assigned area will include, for example: Lead the cross-functional efforts (e.g., Global Market Access & Pricing Team – GMAP / Value and Access Teams – VAT) to deliver close alignment between insights into payer evidence needs, and ensure execution of plans to generate evidence (Integrated Evidence Plan) to support payer value proposition and pricing strategy
  • Guidance to the Medicines Development Lead (MDL) and Medicines Commercial Lead (MCL) consolidating the payer questions/evidence needs for key markets to inform strategy and tactics
  • Input to the evidence generation plan to ensure it will address critical payer questions
  • A market access strategy within the brand plans, fit for purpose and aligned to the overall market access strategy
  • Assist country affiliates in their reimbursement negotiations by integrating country-specific needs into the pricing and market access strategy, value dossier, training on global materials and pricing/negotiation workshops
  • Effective team working with medical and outcomes staff to develop an integrated evidence plan and manage efficient interfaces with key countries
  • Represent the market access voice at the Medicines Commercial Team (MCT) and Medicines Development Team (MDT) and ensure that the market access strategy is reflected in key commercial and development decisions.

Benefits

  • comprehensive benefits program
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service